En la actualidad las personas que viven con VIH-1 o SIDA (PVVS) tienen a su disposición tratamientos antirretrovirales (TAR) altamente eficaces en el control rápido de la viremia tras la infección. No obstante, las PVVS siguen teniendo una esperanza de vida ligeramente inferior a la población no infectada. Las PVVS sufren un proceso de...
-
December 2, 2022 (v1)PublicationUploaded on: March 24, 2023
-
July 19, 2023 (v1)Publication
Some HIV controllers experience immunologic progression with CD4+ T cell decline. We aimed to identify genetic factors associated with CD4+ T cell lost in HIV controllers. A total of 561 HIV controllers were included, 442 and 119 from the International HIV controllers Study Cohort and the Swiss HIV Cohort Study, respectively. No SNP or gene was...
Uploaded on: October 11, 2023 -
February 9, 2024 (v1)Publication
Purpose: Sclerotic chronic GVHD (scGVHD) is characterized by progressive skin fibrosis and frequent refractoriness to available therapies. Aberrant activation of Hedgehog signaling in dermal fibroblasts has been implicated in scGVHD. Here, we report the results of two phase I/II studies (NCT03415867, GETH-TC; NCT04111497, FHD) that evaluated...
Uploaded on: February 11, 2024 -
June 15, 2023 (v1)Publication
The immune factors associated with impaired SARS-CoV-2 vaccine response in elderly people are mostly unknown. We studied individuals older than 60 and younger than 60 years, who had been vaccinated with SARS-CoV-2 BNT162b2 mRNA, before and after the first and second dose. Aging was associated with a lower anti–RBD IgG levels and a decreased...
Uploaded on: June 16, 2023